Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Dolby Laboratories Inc (NYSE: DLB) closed at $67.14 in the last session, down -0.46% from day before closing price of $67.45. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 0.58 million shares were traded. DLB stock price reached its highest trading level at $67.97 during the session, while it also had its lowest trading level at $66.99.
Ratios:
We take a closer look at DLB’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.71. For the most recent quarter (mrq), Quick Ratio is recorded 3.10 and its Current Ratio is at 3.17. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, Robert W. Baird on September 05, 2025, initiated with a Neutral rating and assigned the stock a target price of $74. Barrington Research Upgraded its Mkt Perform to Outperform on June 03, 2024, while the target price for the stock was maintained at $100.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 01 ’25 when MARK ANDREW SHERMAN bought 4,500 shares for $67.56 per share.
YEAMAN KEVIN J sold 36,699 shares of DLB for $2,455,405 on Nov 24 ’25. The President and CEO now owns 114,725 shares after completing the transaction at $66.91 per share. On Nov 25 ’25, another insider, Prophet Tony A, who serves as the Director of the company, sold 3,300 shares for $67.85 each. As a result, the insider received 223,905 and left with 9,107 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DLB now has a Market Capitalization of 6434978304 and an Enterprise Value of 5757936640. As of this moment, Dolby’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.58, and their Forward P/E ratio for the next fiscal year is 14.89. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.47. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.75 while its Price-to-Book (P/B) ratio in mrq is 2.44. Its current Enterprise Value per Revenue stands at 4.268 whereas that against EBITDA is 15.655.
Stock Price History:
The Beta on a monthly basis for DLB is 0.89, which has changed by -0.15685046 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, DLB has reached a high of $89.66, while it has fallen to a 52-week low of $64.02. The 50-Day Moving Average of the stock is -1.45%, while the 200-Day Moving Average is calculated to be -9.17%.
Shares Statistics:
According to the various share statistics, DLB traded on average about 549.82K shares per day over the past 3-months and 787530 shares per day over the past 10 days. A total of 60.80M shares are outstanding, with a floating share count of 60.09M. Insiders hold about 37.11% of the company’s shares, while institutions hold 61.15% stake in the company. Shares short for DLB as of 1763078400 were 2651832 with a Short Ratio of 4.82, compared to 1760486400 on 2175178. Therefore, it implies a Short% of Shares Outstanding of 2651832 and a Short% of Float of 6.529999999999999.
Dividends & Splits
The forward annual dividend rate for DLB is 1.32, which was 1.35 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.020014826. The stock’s 5-year Average Dividend Yield is 1.34.
Earnings Estimates
. The current rating of Dolby Laboratories Inc (DLB) reflects the combined expertise of 4.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $1.37, with high estimates of $1.42 and low estimates of $1.31.
Analysts are recommending an EPS of between $4.36 and $4.21 for the fiscal current year, implying an average EPS of $4.27. EPS for the following year is $4.53, with 2.0 analysts recommending between $4.6 and $4.47.
Revenue Estimates
According to 5 analysts,. The current quarter’s revenue is expected to be $341.26M. It ranges from a high estimate of $378M to a low estimate of $330.7M. As of. The current estimate, Dolby Laboratories Inc’s year-ago sales were $357MFor the next quarter, 5 analysts are estimating revenue of $383.15M. There is a high estimate of $399M for the next quarter, whereas the lowest estimate is $370.23M.
A total of 5 analysts have provided revenue estimates for DLB’s current fiscal year. The highest revenue estimate was $1.46B, while the lowest revenue estimate was $1.4B, resulting in an average revenue estimate of $1.41B. In the same quarter a year ago, actual revenue was $1.35BBased on 3 analysts’ estimates, the company’s revenue will be $1.46B in the next fiscal year. The high estimate is $1.48B and the low estimate is $1.44B.
